BMB Reports Papers in Press available online.

Search Papers In Press
This galley proof is being listed electronically before publishing the final manuscript (It's not final version).

mTOR signalling pathway – A root cause for idiopathic autism?
Harsha Ganesan1, Venkatesh Balasubramanian1, Mahalaxmi Iyer2, Anila Venugopal1, Mohana Devi Subramaniam3, Ssang-Goo Cho4, Balachandar Vellingiri1,*
1Department of Human Genetics and Molecular Biology, Bharathiar University, Coimbatore, Tamil Nadu, India,
2Department of Zoology, Avinashilingam Institute for Home Science and Higher Education for Women, Tamil Nadu, India,
3Department of Genetics and Molecular Biology, Sankara Nethralaya, Chennai, Tamil Nadu, India,
44Department of Stem Cell and Regenerative Biotechnology, Konkuk University, Seoul, South Korea
Autism spectrum disorder (ASD) is a complex neurodevelopmental monogenic disorder with a robust impact in genetics. Idiopathic autism could be defined as a type of autism which does not have a specific causative agent. Among the signalling cascades, mTOR signalling pathway has a pivotal role not just in cell cycle, but also in protein synthesis and regulates the brain homeostasis in ASD patients. The present review highlights the underlying mechanism and the role of altered signalling cascades as a triggering factor in the onset of idiopathic autism. Further, the review discusses how the distorted mTOR signalling pathway, stimulates truncated translation in the neuronal cells and leads to downregulation of protein synthesis at the dendritic spines of the brain. The review concludes by suggesting downstream regulators like p70S6K, eIF4B, eIF4E of mTOR signalling pathway as a promising therapeutic target in idiopathic autistic individuals.
Abstract, Accepted Manuscript(in press) [Submitted on May 9, 2019, Accepted on May 27, 2019]
  Copyright © KSBMB. All rights reserved. / Powered by INFOrang Co., Ltd